Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

GTx's Toremifene 80 Mg Increased Bone Mineral Density In Multiple Clinically Relevant Subpopulations Of Prostate Cancer Patients
GTx, Inc. (Nasdaq: GTXI) announced the presentation of data demonstrating that toremifene 80 mg treatment compared to placebo increased bone mineral density (BMD) in multiple clinically relevant subpopulations of men with prostate cancer on androgen deprivation therapy (ADT). The data, an analysis of results of the recent Phase III clinical trial evaluating toremifene 80 mg for the prevention of bone fractures and treatment of other estrogen deficiency side effects of androgen deprivation therapy in men with prostate cancer, were presented yesterday at the 2009 Annual Meeting of the American Society of Clinical Oncology.
generic viagra online
Comparative Effectiveness Necessary To Weigh New Drugs Against Old Ones, Opinion Piece Says
Patients and physicians "need to know not just whether a new drug outperforms a placebo, but whether it"s a real advance on what"s already on the market," Richard Friedman, a professor of psychiatry at Weill Cornell Medical College, writes in a New York Times opinion piece. According to Friedman, "Doctors and patients alike are inundated by drug company marketing." Friedman states he has seen "scores of patients" who are "eager to get the latest antidepressant or mood stabilizer that promised them tranquility on their TV screens." He continues that these new treatments are not necessarily better than older, proven treatments. Comparative effectiveness research would allow "head-to-head trials comparing new and standard treatments," which is why the practice has "provoked strong resistance from the makers of drugs and devices who fear that their fancy new products may not be any better than current ones," according to Friedman. He concludes, "I"d opt for an old drug with a known track record of efficacy and safety over an expensive newcomer with no added benefit -- any day of the week" (Friedman, New York Times, 5/19).
News of the day
Experts: Big Tobacco Dead By 2047, Possibly Sooner
President Barack Obama"s signature on a bill this week to grant the Food and Drug Administration (FDA) regulatory authority over tobacco was historic, and represents a step in the march to eliminate tobacco use in this country by 2047, two national tobacco experts said recently (June 25).
Public Health

One Size Fits None: New Hope For The Hated Hospital Gown

daily since patients often go through as many as five gowns per day. The current gown is produced for about $3 and lasts for about 40 uses [before it starts degrading due to torn ties, permanent stains, etc.] So, there"s tremendous demand for hospital gowns and room in the market for alternate offerings." This business research then guided the design process, with the students ultimately designing the "Progressive Recovery Collection" to be designed from "smart" textiles. The idea would be to offer more expensive gown options at a higher price point. It"s a market position that is currently unfilled. Welsh summarized, "There are a number of advantages to the UC designs created for Hill-Rom. It"s a product collection designed to fit a varied population, to be aesthetically pleasing and to incorporate therapeutic qualities." In addition, the UC students looked at preliminary ways to make the gowns available to target markets willing to pay something extra for the comfort and dignity of the improved designs. For instance, the items might be available online for pre-order in advance of a planned hospital stay. Said Brandewie, "Items could be available online. Another idea is to have accessories in the gift shop of the hospital, for any patient or visiting loved ones to purchase. We thought that the patient could bring the separates home with them to keep and use in physical therapy." M.B. Reilly University of Cincinnati

Pages: 1 [2] 


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009